a slimming aid made from a southern african cactus is set to be developed by uk firm phytopharm and unileverunder the deal production of the hoodia cactus at phytopharms nursery in south africa will also rise from eight million plants to potentially hundreds of millions said phytopharm chief executive richard dixeyphytopharm will receive an initial fee of £65m from unilever  out of a potential total of £21m  as well as future royalties on product salesthe firm had initially hoped to market a slimming drug from hoodia with pfizeranglodutch food giant unilever will help the pharmaceutical firm develop the snacks containing hoodia extract
